FDA testing has revealed some batches of Zantac and its generic versions had unacceptable levels of NDMA, a chemical linked to cancer.
CBS News' Dr. John LaPook reports.
FDA testing has revealed some batches of Zantac and its generic versions had unacceptable levels of NDMA, a chemical linked to cancer.
CBS News' Dr. John LaPook reports.